FEATURED

The groundbreaking study has prompted calls for businesses and organizations to provide resources and support for CEOs grappling with mental health issues.

The partnership means clinicians at Schweiger Dermatology Group’s Freehold and Verona, New Jersey offices will have access to state-of-the-art melanoma detection technology. For SciBase, we establish a further partner that helps introduce Nevisense to US payers,” said Simon Grant, Chief Executive Officer of SciBase.

The availability of COLOTECTTM 1.0 in Slovakia offers an easy and convenient alternative for accurate screening and detection. “Its sensitivity for detecting colorectal cancers is 88%, and specificity for identifying subjects without advanced colorectal neoplasm is 92%. Most importantly, for early detection, its sensitivity for advanced adenoma is 46%”, Dr. Lucia Starovecká Copák noted.

For the fourth time since 2015, AMT received the prestigious FANUC Sales Growth Award at the FANUC Authorized System Integrator (ASI) Conference. AMT was also recognized for yearly sales of more than 50 FANUC robots in 2022.

PharmaMarketing Summit unites leading pharmaceutical marketing executives and innovative sponsors in an exclusive networking environment.